3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Genitourinary
1
Conditions
Breast Neoplasms
40
Carcinoma, Non-Small-Cell Lung
32
Colorectal Neoplasms
27
Ovarian Neoplasms
23
Neoplasms
23
Lung Neoplasms
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Pancreatic Neoplasms
17
Leukemia, Myeloid, Acute
16
Head and Neck Neoplasms
16
Lymphoma, Non-Hodgkin
15
Neoplasm Metastasis
14
Fallopian Tube Neoplasms
14
Glioblastoma
13
Esophageal Neoplasms
12
Rectal Neoplasms
11
Lymphoma
11
Squamous Cell Carcinoma of Head and Neck
10
Central Nervous System Neoplasms
10
Carcinoma, Ovarian Epithelial
10
Recurrence
9
Melanoma
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Follicular
9
Leukemia
9
Stomach Neoplasms
8
Prostatic Neoplasms
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Liver Neoplasms
7
Interventions
Vincristine
10
Filgrastim
10
Cyclophosphamide
10
Doxorubicin
8
Etoposide
7
Radiotherapy
6
Dactinomycin
6
Carboplatin
6
Granulocyte Colony-Stimulating Factor
5
Topotecan
4
Polymerase Chain Reaction
4
Gene Expression Profiling
4
sargramostim
3
Temozolomide
3
Reverse Transcriptase Polymerase Chain Reaction
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Itraconazole
3
Irinotecan
3
Ifosfamide
3
DNA Methylation
3
Cisplatin
3
Busulfan
3
liposomal amphotericin B
2
ixabepilone
2
X-Rays
2
Voriconazole
2
Therapeutics
2
Stem Cell Transplantation
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Wilms Tumor
×
Drug Therapy
×
Clear all
NCT02649829
2025-04-29
MESODEC
University Hospital, Antwerp
Phase 1/2
Completed
28 enrolled